Abstract
Probiotics can affect the immune homeostasis by altering the gut microbial balance and enhancing the immune system of gut, thus benefits in Inflammatory Bowel Disease, including Crohn’s disease and Ulcerative colitis. Relative gene expression of pro, anti-inflammatory cytokines and other molecules in 2,4,6-trinitrobenzene sulfonic acid-induced colitis mouse model against Lactobacillus plantarum Lp91 (L. plantarum Lp91) was investigated by reverse transcription—quantitative PCR (RT-qPCR) using relative expression software tool (REST 2008 V2.0.7). L. plantarum Lp91 evoked significant down regulation of TNF-α and COX2 to 0.026 and 0.077 fold in colitis mouse model. No significant difference in expression of IL-12a cytokine in colitis mouse challenged with L. plantarum Lp91 was also observed. IL-10 was significantly up-regulated to 37.813 and 1.327 fold in colitis and non-colitis mouse challenged with L. plantarum Lp91. While, other anti-inflammatory markers i.e. COX1, IL-4 and IL-6 were significantly up regulated in colitis mouse challenged with L. plantarum Lp91. MUC2 gene was significantly up regulated to 2.216 fold in non-colitis group. L. plantarum Lp91, an indigenous probiotic culture, the main subject of this project exhibited strong immunemodulatory properties under in vivo conditions in mouse colitis model.
Similar content being viewed by others
References
Sheil B, Shanahan F, O’Mahony L (2007) Probiotic effects on inflammatory bowel disease. J Nutr 137:819S–824S
Fedorak RN, Madsen KL (2004) Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis 10:286–299
Schreiber S, Heinig T, Thiele HG et al (1995) Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 108:1434–1444
Havenaar R, Ten Brink B, Huis Veld JHJ (1992) Selection of strains for probiotic use. In: Fuller R (ed) Probiotics: the scientific basis. Chapman and Hall, London, pp 209–224
McFarland L, Surawicz C, Greenberg R (1994) A randomised placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. J Am Med Assoc 271:1913–1918
Kruis W, Schutz E, Fric P et al (1997) Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 11:853–858
Foligne B, Zoumpopoulou G, Dewulf J et al (2007) A key role of dendritic cells in probiotic functionality. PLoS ONE 2:e313
Madsen KL, Doyle JS, Jewell LD et al (1999) Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116:1107–1114
Sartor RB (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126:1620–1633
Lammers KM, Vergopoulos A, Babel N et al (2005) Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression. Inflamm Bowel Dis 11:447–454
Bibiloni R, Fedorak RN, Tannock GW et al (2005) VSL3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 100:1539–1546
Schultz M, Veltkamp C, Dieleman LA et al (2002) Lactobacillus plantarum 299 V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm Bowel Dis 8:71–80
Gionchetti P, Rizzello F, Venturi A et al (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo controlled trial. Gastroenterology 119:305–309
Gionchetti P, Rizzello F, Helwig U et al (2003) Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124:1202–1209
Gupta P, Andrew H, Kirschner BS et al (2000) Is Lactobacillus GG helpful in children with Crohn’s disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr 31:453–457
FAO/WHO (2002) Working group report on drafting guidelines for the evaluation of probiotics in food London. Ontario, Canada
Christensen HR, Frokiaer H, Pestka JJ (2002) Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 168:171–178
Dombrowicz D, Nutten S, Desreumaux P et al (2001) Role of the high affinity immunoglobulin E receptor in bacterial translocation and intestinal inflammation. J Exp Med 193:25–34
Bustin SA, Benes V, Garson JA et al (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611–622
Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
Rasmussen R (2001) Quantification on the LightCycler. In: Meuer S, Wittwer C, Nakagawara K (eds) Rapid cycle real-time PCR. Methods and applications. Springer Press, Heidelberg, pp 21–34
Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e36
Crittenden R, Karppinen S, Ojanen S et al (2002) In vitro fermentation of cereal dietary fibre carbohydrates by probiotic and intestinal bacteria. J Sci Food Agric 82:781–789
Harris RE (2007) Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer. Subcell Biochem 42:93–126
Wang Q, Takei Y, Kobayashi O et al (2009) Cyclooxygenase 2 modulates killing of cytotoxic T lymphocytes by colon cancer cells. J Clin Biochem Nutr 45:163–170
Brundnak MA (2001) Nutritional regulation of gene expression. Theory Biosci 120:64–75
Miller KS, Brudnak M (1994) Expression cloning: PCR versus episomal vectors for rescue of transfected genes. In: Sarkar G (ed) PCR in neuroscience (Methods in neuroscience, vol 26). Academic Press, Orlando, FL
Borruel N, Carol M, Casellas F et al (2002) Increased mucosal tumour necrosis factor α production in Crohn’s disease can be regulated ex vivo by probiotic bacteria. Gut 51:659–664
Haller D, Bode C, Hammes WP et al (2000) Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 47:79–87
Maassen CB, van Holten-Neelen C, Balk F et al (2000) Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 18:2613–2623
Morita H, He F, Fuse T et al (2002) Adhesion of lactic acid bacteria to caco-2 cells and their effect on cytokine secretion. Microbiol Immunol 46:293–297
Ewaschuk JB, Dieleman LA (2006) Probiotics and prebiotics in chronic inflammatory bowel diseases. World J Gastroenterol 12:5941–5950
Lee JH, Lee B, Lee HS et al (2009) Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis. Int J Colorectal Dis 24:231–237
Pavan S, Desreumaux P, Mercenier A (2003) Use of mouse models to evaluate the persistence, safety and immune modulation capacities of lactic acid bacteria. Clin Diagn Lab Immunol 10:696–701
Perdigon G, Maldonado Galdeano G, Valdez JC et al (2002) Interaction of lactic acid bacteria with the gut immune system. Eur J Clin Nutr 56:S21–S26
Hart AL, Lammers K, Brigidi P et al (2004) Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53:1602–1609
Chen L, Wang X, Cui Y et al (2009) Therapeutic effects of four strains of probiotics on experimental colitis in mice. World J Gastroenterol 15:321–327
Menard O, Butel M, Gaboriau-Routhiau V et al (2008) Gnotobiotic mouse immune response induced by Bifidobacterium sp. strains isolated from infants. Appl Environ Microbiol 74:660–666
Matsuzaki T, Takagi A, Ikemura H et al (2007) Intestinal microflora: probiotics and autoimmunity. J Nutr 137:798S–802S
Mastrangeli G, Corinti S, Butteroni C et al (2009) Effects of live and inactivated VSL#3 probiotic preparations in the modulation of in vitro and in vivo allergen-induced Th2 responses. Int Arch Allergy Immunol 150:133–143
Ulisse S, Gionchetti P, D’Alo S et al (2001) Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. Am J Gastroenterol 96:2691–2699
Hacini-Rachinel F, Gheit H, Luduec J et al (2009) Oral probiotic control skin inflammation by acting on both effector and regulatory T cells. PLoS ONE 4:e4903
Caballero F, Keller K, De Simone C et al (2007) The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 292:G315–G322
Gaudier E, Michel C, Segain JP et al (2005) The VSL#3 probiotic mixture modifies microflora but does not heal chronic dextran sodium sulphate induced colitis or reinforce the mucus barrier in mice. J Nutr 135:2753–2761
Mattar AF, Teitelbaum DH, Drongowski RA et al (2002) Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model. Pediatr Surg Int 18:586–590
Acknowledgments
We gratefully acknowledge the Director, National Dairy Research Institute (NDRI, Karnal, India) for providing facilities to carry out the study. We thank Dr. N.P. Shah (Australia) for kindly providing the standard Lactobacillus culture. The financial support received from Indian Council of Agricultural Research (ICAR, India) in terms of providing fellowship to the first author of the paper to carry out his doctoral programme is greatly appreciated.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Duary, R.K., Bhausaheb, M.A., Batish, V.K. et al. Anti-inflammatory and immunomodulatory efficacy of indigenous probiotic Lactobacillus plantarum Lp91 in colitis mouse model. Mol Biol Rep 39, 4765–4775 (2012). https://doi.org/10.1007/s11033-011-1269-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-011-1269-1